EUVIMEDEUVIMED entdecken
Multizentrische StudieQuerschnittstudie

High prevalence of HLA-B51 and ocular involvement in Behçet’s disease: a multicenter cross-sectional study

Shamma Ahmad Al Nokhatha, Najla Aljaberi, Jawaher Al Zeyoudi, Ahlam Almarzooqi, Farah Soukieh, Mumtaz Khan

Rheumatology International · 2025

DOI: 10.1007/s00296-025-05892-6 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Rheumatology International, 2025. Verfasst von Shamma Ahmad Al Nokhatha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Division, Department of Rheumatology, Tawam Hospital, Al Ain, United Arab Emirates. shamma.alnokhatha@gmail.com. Hauptthemen laut MEDLINE: Behcet Syndrome, HLA-B51 Antigen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Behçet's disease (BD) is a rare multisystem vasculitis. Globally, BD exhibits a unique geographic distribution, with the highest prevalence along the historic Silk Road. To study the demographics, clinical characteristics, and outcomes of BD in the United Arab Emirates (UAE). A multicenter retrospective chart review study was conducted at hospitals in the UAE from 2008 to 2024. All adult and pediatric patients who were diagnosed with BD by a rheumatologist and treated within the timeframe were included in the study while those who received any alternative final diagnosis were excluded. The results were analyzed using descriptive and inferential statistics. One hundred and twenty-three patients were treated and monitored for BD. Most were female (n = 70, 57%). Their median age was 32 years (24-41), and approximately two-thirds were Emirati (n = 82, 67%). Twelve patients (10%) had a family history of BD, including 7 (6%) with first-degree BD. The time from the initial symptoms to diagnosis was 11.9 months (2.3-31.0). The most common clinical manifestations were oral ulcers (n = 99, 81%), arthralgia (n = 63, 51%), genital ulcers (n = 62, 50%), and ocular involvement (n = 37, 30%). Most of the patients were HLA-B51 positive (n = 92, 84%). At diagnosis, 36 (29%) met the ISG criteria, 73 (59%) met the ICBD criteria, and 50 (41%) met neither criteria. The male patients exhibited more major organ involvement (ocular, neurological, vascular, and cardiac), greater use of corticosteroids and anti-TNFa medications, and greater disease activity than the female patients. Among the patients with isolated ocular manifestations (n = 9) who met neither classification criteria, most were female (56%), with a median age of 37 years (26.5-3.5). None had a family history of autoimmune conditions, and all were HLA-B51 positive. Most of these patients (n = 8, 89%) received corticosteroids, 5 (56%) received azathioprine, and 2 (22%) received anti-TNFa therapies. These findings provide insights into the clinical profile of BD in the UAE. Notably, we found a high proportion of patients with positive HLA-B51 and ocular manifestation. Further research with larger sample sizes is needed to better understand these associations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Behcet SyndromeHLA-B51 AntigenHumansFemaleMaleAdultRetrospective StudiesCross-Sectional StudiesUnited Arab EmiratesPrevalenceYoung Adult

Stichwörter der Autor:innen

Behçet’sColchicineHLA-B51United Arab EmiratesUveitisVasculitis

Substanzen

HLA-B51 Antigen

Autor:innen und Institutionen

  • Rheumatology Division, Department of Rheumatology, Tawam Hospital, Al Ain, United Arab Emirates. shamma.alnokhatha@gmail.com.
  • Internal Medicine Department, College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates. shamma.alnokhatha@gmail.com.
  • Internal Medicine Department, College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates.
  • Pediatrics Division, Department of Pediatrics, Tawam Hospital, Al Ain, United Arab Emirates.
  • Department of Pediatrics, College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates.
  • Division of Rheumatology, Department of Rheumatology, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.

Zitieren

APA

Nokhatha, S. A. A., Aljaberi, N., Zeyoudi, J. A., Almarzooqi, A., Soukieh, F., & Khan, M. (2025). High prevalence of HLA-B51 and ocular involvement in Behçet’s disease: a multicenter cross-sectional study. Rheumatology International. https://doi.org/10.1007/s00296-025-05892-6

Vancouver

Nokhatha SAA, Aljaberi N, Zeyoudi JA, Almarzooqi A, Soukieh F, Khan M. High prevalence of HLA-B51 and ocular involvement in Behçet’s disease: a multicenter cross-sectional study. Rheumatology International. 2025. doi:10.1007/s00296-025-05892-6

BibTeX
@article{Nokhatha2025,
  author = {Nokhatha, Shamma Ahmad Al and Aljaberi, Najla and Zeyoudi, Jawaher Al and Almarzooqi, Ahlam and Soukieh, Farah and Khan, Mumtaz},
  title = {High prevalence of HLA-B51 and ocular involvement in Behçet’s disease: a multicenter cross-sectional study},
  journal = {Rheumatology International},
  year = {2025},
  doi = {10.1007/s00296-025-05892-6}
}
Kostenlos starten →